Previous Article | Next Article ![]()
Applied and Environmental Microbiology, August 2006, p. 5615-5617, Vol. 72, No. 8
0099-2240/06/$08.00+0 doi:10.1128/AEM.00722-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
| SHORT REPORT |
Antony Leplingard,2,
Denis D. G. Mater,1,
Agnès Mogenet,3
Rachel Michelin,1
Isabelle Seksek,2
Philippe Marteau,4
Joël Doré,1
Jean-Louis Bresson,4 and
Gérard Corthier1*
Unité d'Ecologie et de Physiologie du Système Digestif, INRA, 78350 Jouy en Josas, France,1 Danone Vitapole, 91767 Palaiseau, France,2 Centre d'Investigation Clinique AP-HP/INSERM, Université René Descartes and Hôpital Necker-Enfants Malades, 75015 Paris, France,3 Service de Gastro-Entérologie, Université René Descartes and Hôpital Européen Georges Pompidou, 75908 Paris, France4
Received 29 March 2006/ Accepted 9 May 2006
A human trial was carried out to assess the ileal and fecal survival of Lactobacillus casei DN-114 001 ingested in fermented milk. Survival rates were up to 51.2% in the ileum and 28.4% in the feces. The probiotic bacterium has the capacity to survive during its transit through the human gut.
R. Oozeer and A. Leplingard contributed equally to this work.
Present address: Syndifrais, 42 rue de Châteaudun, 75314 Paris cedex 09, France.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»